Atra stock forecast.

Discover historical prices for ATRA stock on Yahoo Finance. View daily, weekly or monthly format back to when Atara Biotherapeutics, Inc. stock was issued.

Atra stock forecast. Things To Know About Atra stock forecast.

16 equities research analysts have issued twelve-month price targets for SoFi Technologies' stock. Their SOFI share price targets range from $3.00 to $15.00. On average, they anticipate the company's share price to reach $8.78 in the next year. This suggests a possible upside of 12.1% from the stock's current price.8 brokers have issued 12-month target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they predict the company's stock price to reach $16.05 in the next twelve months. This suggests a possible upside of 833.1% from the stock's current price. View analysts price targets for CRLBF …Atara Biotherapeutics Stock Forecast 30 Oct. Presumably, on 10/30/2023, the price of shares will be in the range of $1.28 - $1.32. A $0.04 range width can provide 3.34% volatility. The weighted average price of this range is at $1.29, which is $0.01 lower than the previous day's weighted average price.The Fly Atara Biotherapeutics downgraded to In Line from Outperform ... The Fly Atara Biotherapeutics price target lowered to $13 from $19 a... The Fly Atara Biotherapeutics downgraded to Neutral from Buy at H.C.... The Fly Atara Biotherapeutics downgraded to Neutral from Buy at Mizu... The Fly Atara Biotherapeutics’ ATA188 did not meet ...

Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58.

Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.

According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Fuelcell Energy share forecasts, stock quote and buy / sell signals below. According to present data Fuelcell Energy's FCEL shares and potentially its market environment have been in bearish cycle last 12 months (if exists).The Fly Atara Biotherapeutics downgraded to In Line from Outperform ... The Fly Atara Biotherapeutics price target lowered to $13 from $19 a... The Fly Atara Biotherapeutics downgraded to Neutral from Buy at H.C.... The Fly Atara Biotherapeutics downgraded to Neutral from Buy at Mizu... The Fly Atara Biotherapeutics’ ATA188 did not meet ...Dec 1, 2023 · Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.

34 Wall Street research analysts have issued 12 month price objectives for PayPal's stock. Their PYPL share price targets range from $55.00 to $118.00. On average, they expect the company's share price to reach $78.77 in the next year. This suggests a possible upside of 32.0% from the stock's current price.

Nov 7, 2023 · Analyst projections state that ATRA is forecast to be at a low of $1.40 and a high of $31.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2248.48% from its current level, while the stock would need to crash -6.06% from its current level to reach the projected low.

Oct 27, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Atara Biotherapeutics Inc. Watch list Set a price target alert After Hours Last Updated: Nov 22, 2023 7:55 p.m. EST Delayed quote $ 0.5402 -0.03 -5.56% After Hours Volume: 53.15K Advanced...Facebook Stock Forecast 2023, 2024, 2025. Tesla stock predictions for December 2024. The forecast for beginning of December 330. Maximum value 365, while minimum 323. Averaged Tesla stock price for month 341. Price at the end 344, change for December 4.24%.Oct 24, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. GDX Signals & Forecast. Mostly positive signals in the chart today. The VanEck Vectors Gold Miners ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long …Fintel reports that on November 9, 2023, Mizuho downgraded their outlook for Atara Biotherapeutics (NASDAQ:ATRA) from Buy to Neutral . Analyst Price Forecast Suggests 1,140.58% Upside As of ...

Google stock prediction on Friday, December, 29: 137 dollars, maximum 148, minimum 126. In 4 weeks Google stock price forecast on Monday, January, 1: 139 dollars, maximum 150, minimum 128. Google stock prediction on Tuesday, January, 2: 140 dollars, maximum 151, minimum 129. The forecast is updated on daily basis.According to 30 stock analysts, the average 12-month stock price forecast for Tesla stock is $238.87, which predicts a decrease of -2.16%. The lowest target is $85 and the highest is $380. On average, analysts rate Tesla stock as a hold.4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.Atara Biotherapeutics Stock Forecast. Is Atara Biotherapeutics Stock Undervalued? The current Atara Biotherapeutics [ ATRA] share price is $0.65. The Score for ATRA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal. ATRA is currently trading in the 10-20% percentile range relative to its historical ...Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025.During the last day, the stock moved $0.0269 between high and low, or 3.59%. For the last week the stock has had daily average volatility of 2.76% . Our recommended stop-loss: $0.740 (-4.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 46 days ago.)

We use our expertise to forecast stock prices. [email protected]; Market Opinions. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. AIStockFinder will not accept liability for any loss or …

Aug 8, 2023 · Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? S Stock 12 Months Forecast. Based on 20 Wall Street analysts offering 12 month price targets for SentinelOne in the last 3 months. The average price target is $18.97 with a high forecast of $23.00 and a low forecast of $16.50. The average price target represents a 5.86% change from the last price of $17.92.hace 6 días ... The trading price of Atara Biotherapeutics Inc (NASDAQ:ATRA) closed lower on Monday, November 27, closing at $0.63, -3.22% lower than its ...Nov 24, 2023 · Atara Biotherapeutics Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.57. Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.481%. Pessimistic target level: 0.56. Optimistic target level: 0.58. Nov 7, 2023 · Analyst projections state that ATRA is forecast to be at a low of $1.40 and a high of $31.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2248.48% from its current level, while the stock would need to crash -6.06% from its current level to reach the projected low. The BOIL ETF price gained 0.81% on the last trading day (Thursday, 30th Nov 2023), rising from $36.00 to $36.29. During the last trading day the ETF fluctuated 6.05% from a day low at $35.20 to a day high of $37.33. The price has fallen in 8 of the last 10 days and is down by -29.62% for this period. Volume fell on the last day by -27 …THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its …

Mullen Automotive Stock Forecast. Stock Price Forecast. There is currently no analyst price target forecast available for MULN stock. Analyst Consensus: n/a. Target Low Average Median High; Price: n/a: n/a: n/a: n/a: Change: n/a: n/a: n/a: n/a: Analyst Ratings. There are currently no analyst ratings available for MULN. Recommendation …

The OptiNose Inc. stock price gained 1.63% on the last trading day (Wednesday, 29th Nov 2023), rising from $1.23 to $1.25. During the last trading day the stock fluctuated 4.02% from a day low at $1.21 to a day high of $1.26. The price has risen in 6 of the last 10 days.

Atara Biotherapeutics stock price predictions for 2022 using artificial intelligence. How much will Atara Biotherapeutics stock be worth in 2022? Target price in 2022.The consensus price target of analysts on Wall Street is $10.89, which implies an increase of 97.34% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.00 and $28.00 respectively. As a result, ATRA is trading at a discount of -9555.17% off the target high and -244.83% off the low.Amazon.com Inc EBIT Forecast for 2023 - 2025 - 2030. In the last three years, Amazon.com Inc's EBIT has decreased from $14.54B to $12.25B – a 15.77% drop! For the next year, analysts are expecting EBIT to reach $46.04B – an increase of 275.91%. Over the next eight years, experts predict that EBIT will grow by 2070.64%.Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —. Atara Biotherapeutics Stock Forecast 30 Oct. Presumably, on 10/30/2023, the price of shares will be in the range of $1.28 - $1.32. A $0.04 range width can provide 3.34% volatility. The weighted average price of this range is at $1.29, which is $0.01 lower than the previous day's weighted average price.34 Wall Street research analysts have issued 12 month price objectives for PayPal's stock. Their PYPL share price targets range from $55.00 to $118.00. On average, they expect the company's share price to reach $78.77 in the next year. This suggests a possible upside of 32.0% from the stock's current price.Get The Latest NEOS Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ... Market Share, Revenue, and Forecasts 2022 to 2028. October 2, 2022 | marketwatch.com. Attention Deficit Hyperactivity Market by Size Estimation, Share Analysis with Recent Developments, Business prospects and …Get the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.21 nov 2023 ... On the technical perspective front, indicators give ATRA a short term outlook of 100% Sell on average. Looking at the stock's medium term ...We use our expertise to forecast stock prices. [email protected]; Market Opinions. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. AIStockFinder will not accept liability for any loss or …Instagram:https://instagram. smile direct chapter 11nyse mmm comparebest bank stocks to buy right nowbest stock options software Earnings Date. Feb 06, 2024 - Feb 12, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 3.94. Fair Value is the appropriate price for the shares of a company, based ...Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. tradealgo ipofinancial planners in rhode island Nov 16, 2023 · Atara Biotherapeutics stock forecast for 18.11.2023. Estimated Average Forecasted Atara Biotherapeutics Price: 1.92 Positive intraday dynamics of the instrument is expected with 2.384% volatility is expected. the carson group Nov 30, 2023 · What is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET... Their ATRA share price targets range from $25.00 to $31.00. On average, they expect the company's stock price to reach $28.00 in the next year. This suggests a possible upside of 4,490.2% from the stock's current price. View analysts price targets for ATRA or view top-rated stocks among Wall Street analysts.